MUMBAI, India, Aug. 3, 2023 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), today announced its consolidated results for the first quarter (Q1) ended 30th June 2023. Consolidated Financial Highlights (In INR Crores) Particulars Q1 FY24 Q1 FY23 YoY Growth Q4 FY23 QoQ…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.